A quantitative systems pharmacology modeling platform for evaluating triglyceride profiles in patients with high triglycerides receiving evinacumab
Abstract A model to quantitatively characterize the effect of evinacumab, an investigational monoclonal antibody against angiopoietin‐like protein 3 (ANGPTL3) on lipid trafficking is needed. A quantitative systems pharmacology (QSP) approach was developed to predict the transient responses of differ...
Enregistré dans:
Auteurs principaux: | Masood Khaksar Toroghi, Jim Bosley, Lyn M. Powell, Yi Zhang, Feng Yang, Xia Pu, John D. Davis, Nidal Al‐Huniti |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Wiley
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/f2c85718b9bd447bb1c865f81dfe8b6c |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Population pharmacokinetics and exposure–response modeling for evinacumab in homozygous familial hypercholesterolemia
par: Xia Pu, et autres
Publié: (2021) -
Genetic variation in SULF2 is associated with postprandial clearance of triglyceride-rich remnant particles and triglyceride levels in healthy subjects.
par: Niina Matikainen, et autres
Publié: (2013) -
Pharmacological inhibition of adipose triglyceride lipase corrects high-fat diet-induced insulin resistance and hepatosteatosis in mice
par: Martina Schweiger, et autres
Publié: (2017) -
Endothelial lipase mediates efficient lipolysis of triglyceride-rich lipoproteins.
par: Sumeet A Khetarpal, et autres
Publié: (2021) -
Low HDL and high triglycerides predict COVID-19 severity
par: Lluís Masana, et autres
Publié: (2021)